Allengers Medical Systems Ltd. (AMSL) recorded revenues of Rs. 874 Crore for the financial year ending March 31, 2025. In the same period, credit rating agency CRISIL reaffirmed its ‘CRISIL A+/Stable/CRISIL A1’ ratings on AMSL’s bank facilities — a reflection of the company’s strong market position in India’s X-ray-based medical equipment industry and its robust financial risk profile.
What the CRISIL A+ Rating Means
CRISIL’s A+ rating on bank facilities signals that Allengers carries a very strong degree of safety regarding timely servicing of financial obligations. The ‘Stable’ outlook reflects no expected change in this rating over the near term. This is relevant to Allengers’ buyers and partners worldwide, including Euronoxx Medical Group, as it confirms financial reliability and operational continuity.
Company Profile at a Glance
Allengers Medical Systems Ltd. was incorporated on July 30, 1992 and is registered in Delhi, India. With 1,882 employees as of August 2025, it operates across multiple product categories including X-ray systems, digital radiography systems, angiography, C-Arms, mammography, cath labs, and ECG/EEG/EMG systems. It holds certifications including CE, US FDA, ISO 13485:2016, ICMED 13485:2019, AERB, and BIS.